These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 19746839)

  • 1. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
    Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
    Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems.
    Sandri G; Bonferoni MC; Gökçe EH; Ferrari F; Rossi S; Patrini M; Caramella C
    J Microencapsul; 2010; 27(8):735-46. PubMed ID: 21034366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
    Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
    Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
    Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
    J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.
    Gokce EH; Sandri G; Bonferoni MC; Rossi S; Ferrari F; Güneri T; Caramella C
    Int J Pharm; 2008 Nov; 364(1):76-86. PubMed ID: 18725276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
    Hu FQ; Wu MZh; Yuan H; Zhang HH
    Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.
    Shah KA; Date AA; Joshi MD; Patravale VB
    Int J Pharm; 2007 Dec; 345(1-2):163-71. PubMed ID: 17644288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
    Yang ZQ; Xu J; Pan P; Zhang XN
    Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
    Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
    J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.
    Puglia C; Blasi P; Rizza L; Schoubben A; Bonina F; Rossi C; Ricci M
    Int J Pharm; 2008 Jun; 357(1-2):295-304. PubMed ID: 18343059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine a-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes.
    Gökçe EH; Sandri G; Eğrilmez S; Bonferoni MC; Güneri T; Caramella C
    Curr Eye Res; 2009 Nov; 34(11):996-1003. PubMed ID: 19958116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.
    Bikkad ML; Nathani AH; Mandlik SK; Shrotriya SN; Ranpise NS
    J Liposome Res; 2014 Jun; 24(2):113-23. PubMed ID: 24131382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery.
    Başaran E; Demirel M; Sirmagül B; Yazan Y
    J Microencapsul; 2010; 27(1):37-47. PubMed ID: 19545226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
    Müller RH; Runge S; Ravelli V; Mehnert W; Thünemann AF; Souto EB
    Int J Pharm; 2006 Jul; 317(1):82-9. PubMed ID: 16580159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of liposomal cobalamin hydrogel for atopic dermatitis therapy.
    Jung SH; Cho YS; Jun SS; Koo JS; Cheon HG; Shin BC
    Pharmazie; 2011 Jun; 66(6):430-5. PubMed ID: 21699082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
    Müller RH; Runge SA; Ravelli V; Thünemann AF; Mehnert W; Souto EB
    Eur J Pharm Biopharm; 2008 Mar; 68(3):535-44. PubMed ID: 17804210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Int J Pharm; 2004 Jun; 278(1):71-7. PubMed ID: 15158950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia.
    Münster U; Nakamura C; Haberland A; Jores K; Mehnert W; Rummel S; Schaller M; Korting HC; Zouboulis ChC; Blume-Peytavi U; Schäfer-Korting M
    Pharmazie; 2005 Jan; 60(1):8-12. PubMed ID: 15700772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.